BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10429209)

  • 1. Structural and kinetic analysis of drug resistant mutants of HIV-1 protease.
    Mahalingam B; Louis JM; Reed CC; Adomat JM; Krouse J; Wang YF; Harrison RW; Weber IT
    Eur J Biochem; 1999 Jul; 263(1):238-45. PubMed ID: 10429209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining mutations in HIV-1 protease to understand mechanisms of resistance.
    Mahalingam B; Boross P; Wang YF; Louis JM; Fischer CC; Tozser J; Harrison RW; Weber IT
    Proteins; 2002 Jul; 48(1):107-16. PubMed ID: 12012342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes.
    Mahalingam B; Louis JM; Hung J; Harrison RW; Weber IT
    Proteins; 2001 Jun; 43(4):455-64. PubMed ID: 11340661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants.
    Kozísek M; Bray J; Rezácová P; Sasková K; Brynda J; Pokorná J; Mammano F; Rulísek L; Konvalinka J
    J Mol Biol; 2007 Dec; 374(4):1005-16. PubMed ID: 17977555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation.
    Liu F; Kovalevsky AY; Louis JM; Boross PI; Wang YF; Harrison RW; Weber IT
    J Mol Biol; 2006 May; 358(5):1191-9. PubMed ID: 16569415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.
    Hong L; Zhang XC; Hartsuck JA; Tang J
    Protein Sci; 2000 Oct; 9(10):1898-904. PubMed ID: 11106162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.
    Park JH; Sayer JM; Aniana A; Yu X; Weber IT; Harrison RW; Louis JM
    Biochemistry; 2016 Apr; 55(16):2390-400. PubMed ID: 27039930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics.
    Agniswamy J; Louis JM; Roche J; Harrison RW; Weber IT
    PLoS One; 2016; 11(12):e0168616. PubMed ID: 27992544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.
    Tie Y; Boross PI; Wang YF; Gaddis L; Liu F; Chen X; Tozser J; Harrison RW; Weber IT
    FEBS J; 2005 Oct; 272(20):5265-77. PubMed ID: 16218957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M.
    Kovalevsky AY; Tie Y; Liu F; Boross PI; Wang YF; Leshchenko S; Ghosh AK; Harrison RW; Weber IT
    J Med Chem; 2006 Feb; 49(4):1379-87. PubMed ID: 16480273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters.
    Shen CH; Wang YF; Kovalevsky AY; Harrison RW; Weber IT
    FEBS J; 2010 Sep; 277(18):3699-714. PubMed ID: 20695887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir.
    Liu F; Kovalevsky AY; Tie Y; Ghosh AK; Harrison RW; Weber IT
    J Mol Biol; 2008 Aug; 381(1):102-15. PubMed ID: 18597780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
    Bandaranayake RM; Kolli M; King NM; Nalivaika EA; Heroux A; Kakizawa J; Sugiura W; Schiffer CA
    J Virol; 2010 Oct; 84(19):9995-10003. PubMed ID: 20660190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/L90M mutants based on QM and QM/MM calculations.
    Saen-oon S; Aruksakunwong O; Wittayanarakul K; Sompornpisut P; Hannongbua S
    J Mol Graph Model; 2007 Nov; 26(4):720-7. PubMed ID: 17543558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site.
    Mahalingam B; Wang YF; Boross PI; Tozser J; Louis JM; Harrison RW; Weber IT
    Eur J Biochem; 2004 Apr; 271(8):1516-24. PubMed ID: 15066177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex.
    Maschera B; Darby G; Palú G; Wright LL; Tisdale M; Myers R; Blair ED; Furfine ES
    J Biol Chem; 1996 Dec; 271(52):33231-5. PubMed ID: 8969180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.
    Muzammil S; Ross P; Freire E
    Biochemistry; 2003 Jan; 42(3):631-8. PubMed ID: 12534275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference between D30N and L90M in selection and development of protease inhibitor-resistant human immunodeficiency virus type 1.
    Sugiura W; Matsuda Z; Yokomaku Y; Hertogs K; Larder B; Oishi T; Okano A; Shiino T; Tatsumi M; Matsuda M; Abumi H; Takata N; Shirahata S; Yamada K; Yoshikura H; Nagai Y
    Antimicrob Agents Chemother; 2002 Mar; 46(3):708-15. PubMed ID: 11850252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel HIV PR inhibitors with C4-substituted bis-THF and bis-fluoro-benzyl target the two active site mutations of highly drug resistant mutant PR
    Agniswamy J; Kneller DW; Ghosh AK; Weber IT
    Biochem Biophys Res Commun; 2021 Aug; 566():30-35. PubMed ID: 34111669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo.
    Ermolieff J; Lin X; Tang J
    Biochemistry; 1997 Oct; 36(40):12364-70. PubMed ID: 9315877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.